Braveheart Bio, Inc. filed a Form 8-K on November 6, 2026, disclosing that the company and Hengrui Pharma presented data from a 52-week open-label extension of a Phase 2 study of HRS/BHB-1893 in obstructive hypertrophic cardiomyopathy at the American Heart Association Scientific Sessions 2026.
Director Ashraf Wagih Lotfi filed a Form 4 with the SEC on November 6, 2026, disclosing an automatic grant of 11,100 shares of CVD Equipment Corp common stock received on November 5, 2026, under the company's Director Compensation Plan.
The company is developing elraglusib, a small molecule designed to enter cancer cells and block the enzyme glycogen synthase kinase-3 beta. It has not generatedRevenuefrom product sales since its inception, according to its quarterly report.
Addentax is a NevadaHolding Companythat conducts its operations through subsidiaries in the PRC. The group is engaged in garment manufacturing, logistics services, consulting services and financing services.
ADTRAN provides networking and communications platforms, software, systems and services for carrier networks,Data Centerinterconnect for private enterprise networks and mission critical infrastructure. Its global headquarters are in Huntsville, Alabama, and its European headquarters are in Munich, Germany. It reports two segments, Network Solutions and …
AEVEX describes itself as a defense technology prime contractor and an enabler of U.S. unmanned systems missions, including precision strike launched effects, loitering munitions and intelligence, surveillance and reconnaissance. It reports through two segments, Tactical Systems and Global Solutions.
The company was formed as a Delaware corporation on July 19, 2024 to complete a direct listing and to build an AI-powered ecosystem by acquiring and integrating businesses. It had 70,662,761 shares of common stock outstanding as of August 11, 2026.
AIM is an immuno-pharma company focused on its lead product, Ampligen (rintatolimod), for the treatment of late stage pancreatic cancer.
The company operates 31 centers across 20 states and Canada as of November 6, 2026 and delivers its proprietary AirSculpt procedures, which remove unwanted fat and tighten skin in a minimally invasive procedure.
AMC Robotics develops hardware and software for intelligent robotics, including its Kyro quadruped robotic platform for inspection, security and operational tasks.